Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin

Both ORA-D-013-1 and ORA-D-013-2 will treat T2D patients who have inadequate glycemic control over a period of 6 to 12 months

447
Advertisement

OramedOramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D).

The clinical-stage pharmaceutical company focused on the development of oral drug delivery systems said the patients were screened at U.S. sites participating in Oramed’s ORA-D-013-1 trial, one of two Phase 3 trials being conducted in accordance with U.S. Food and Drug Administration approved protocols.

The Phase 3 trials called ORA-D-013-1 and ORA-D-013-2 will treat T2D patients who have inadequate glycemic control over a period of 6 to 12 months.

The placebo-controlled, double-blinded, multi-center randomized trials will recruit a total of 1,125 patients to evaluate the efficacy and safety of ORMD-0801. Efficacy data will become available after all patients have completed the first 6-month treatment period.

Oramed CEO Nadav Kidron said, “ORMD-0801 is the first oral insulin capsule to achieve the requisite efficacy and safety data enabling us to run the world’s first FDA Phase 3 oral insulin trial. Oramed is proud to lead the field in reaching this very significant diabetes treatment milestone.”

Know about the study

ORA-D-013-1 is recruiting 675 patients who are at present on 1, 2 or 3 oral glucose-lowering agents through 75 clinical sites throughout the United States.

The primary endpoint of the study is aimed at comparing the efficacy of ORMD-0801 to placebo in improving glycemic control as assessed by A1c, with a secondary endpoint of assessing the change from baseline in fasting plasma glucose at 26 weeks.

(With inputs from The OnLook News Research Bureau)

Trending News

If you like this article and if you feel it will be helpful for others to understand on the subject, please share it. You can also follow us on Twitter,  Facebook & Linkedin

Also read: Avoid these 5 foods for healthy heart and sound lifestyle

Trending News